Global Medical Director, Global Medical Affairs Hematology TACSL Behring, Bern, SwitzerlandBern, Bern, Switzerland
PB0557 - Efficacy and safety of rVIII-SingleChain in people with hemophilia A: Interim results from a non-interventional study
Monday, June 24, 202413:45 – 14:45 ICT
PB1178 - Validation of a neutralizing antibody (NAb) assay with extended reportable range for etranacogene dezaparvovec, an adeno-associated virus serotype 5 (AAV5)-based gene therapy for adult hemophilia B
Tuesday, June 25, 202413:45 – 14:45 ICT
